ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,039Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1844

$965K Total Retail Price of All Prescriptions

Rank: 54 out of 1844

541 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 17,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 959 864 1 7
LEVOTHYROXINE SODIUM 938 847 2 1
SIMVASTATIN 853 736 3 3
HYDROCODONE-ACETAMINOPHEN 806 549 S3 4 2
POLYETHYLENE GLYCOL 3350 546 532 5 39
WARFARIN SODIUM 541 519 6 13
OMEPRAZOLE 522 423 7 5
CITALOPRAM HBR 487 477 8 19
HYDROCHLOROTHIAZIDE 442 400 9 9
LISINOPRIL 399 345 10 4
POTASSIUM CHLORIDE 391 368 11 16
AMLODIPINE BESYLATE 352 329 12 6
NAMENDA 345 332 13 33
TRAMADOL HCL 293 254 14 18
DONEPEZIL HCL 267 267 15 26
ESCITALOPRAM OXALATE 261 237 16 52
METFORMIN HCL 244 210 17 8
CARVEDILOL 240 228 18 22
CARBIDOPA-LEVODOPA 231 218 19 86
CIPROFLOXACIN HCL 220 203 20 62
ATENOLOL 187 171 21 17
AZITHROMYCIN 180 160 22 37
LANTUS SOLOSTAR 166 154 23 97
LOSARTAN POTASSIUM 166 166 23 24
ATORVASTATIN CALCIUM 165 157 25 12
METOPROLOL TARTRATE 159 159 26 11
CLOPIDOGREL 152 152 27 34
NITROGLYCERIN PATCH 150 150 28 173
GABAPENTIN 143 112 29 15
EXELON 142 134 30 112
RANITIDINE HCL 140 129 31 38
METOPROLOL SUCCINATE 136 129 32 14
SERTRALINE HCL 134 109 33 21
MIRTAZAPINE 129 126 34 49
ZOLPIDEM TARTRATE 129 125 34 23
NITROFURANTOIN MONO-MACRO 123 123 36 151
PRAVASTATIN SODIUM 117 87 37 10
KLOR-CON M20 114 65 38 54
TAMSULOSIN HCL 106 91 39 27
TAMIFLU 105 100 40 296
ENALAPRIL MALEATE 100 100 41 69
CLONIDINE HCL 97 74 42 64
GLIPIZIDE ER 96 81 43 79
ALENDRONATE SODIUM 96 93 43 25
RISPERIDONE 88 88 45 65
ISOSORBIDE MONONITRATE ER 88 82 45 59
OXYBUTYNIN CHLORIDE ER 87 82 47 126
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 67 48 20
FAMOTIDINE 86 86 48 63
QUETIAPINE FUMARATE 84 76 50 82
BENAZEPRIL HCL 83 83 51 75
SPIRONOLACTONE 82 69 52 60
PLAVIX 80 80 53 61
CYMBALTA 78 54 54 36
FLUOXETINE HCL 76 70 55 41
PREDNISONE 75 63 56 40
AMOXICILLIN 74 67 57 101
ALLOPURINOL 73 73 58 29
NOVOFINE AUTOCOVER 73 73 58 339
LANTUS 73 64 58 42
NEXIUM 73 43 58 31
TRAZODONE HCL 70 53 62 43
ROPINIROLE HCL 70 52 62 76
ARICEPT 70 70 62 275
OXYCODONE HCL 69 48 S2 65 104
CEPHALEXIN 68 61 66 56
OXYCONTIN 68 66 S2 66 144
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 56 66 73
ADVAIR DISKUS 65 41 69 51
LAMOTRIGINE 65 65 69 174
SINGULAIR 64 34 71 102
IPRATROPIUM-ALBUTEROL 60 49 72 113
BACLOFEN 60 18 72 119
MECLIZINE HCL 59 46 74 142
LITHIUM CARBONATE 57 50 75 295
ALBUTEROL SULFATE 55 54 76 115
DILTIAZEM ER 55 53 76 200
DETROL LA 54 30 78 217
IBUPROFEN 53 33 79 89
CELEBREX 53 42 79 91
FENTANYL 51 39 S2 81 66
OLANZAPINE 51 51 81 117
PRAMIPEXOLE DIHYDROCHLORIDE 51 51 81 193
LOVASTATIN 50 37 84 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.